Clinical Trial Update: Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MK-1942 added to stable antidepressant therapy in treatment-resistant depression was terminated, with results posted on 2024-09-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• MK-1942

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Treatment Resistant Depression | Phase 2 | Status: TERMINATED | Results posted: 2024-09-19